Contineum Therapeutics, Inc. Class A Common Stock

CTNM us
$12.56
▲ +0.07 (+0.56%)
Volume: 404,929 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 13
  • 21d momentum -26.2%
  • MA aligned bearish
  • RSI 31
🎯 Pullback 65
  • RSI 31 near lows
  • Near lower Bollinger band
  • -15.0% vs 20MA
💎 Value 58
  • -29% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)31.4
MACD-0.299
MA trendBearish
ATR7.68%
21d mom.-26.2%
63d mom.-11.5%
vs 20MA-15.0%
RVOL(20)0.74×
52w low · 9 52w high · 18
-29.4% from 52-week high
20d support 11 · resistance 18

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$470M
PER—
PBR1.96
PSR—
EPS$-1.53
ROE-24.0%
ROA-23.0%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-6.90
week1M3M6M1YYTD
-7.17% -26.20% -11.49% -7.99% +19.62% +10.27%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
0/10
🐻 Bear
10/10

14d momentum -24.79%, daily vol 3.84%. Contineum Therapeutics, Inc. Class A Common Stock sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.